These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32385806)

  • 41. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
    Kutyifa V; Stockburger M; Daubert JP; Holmqvist F; Olshansky B; Schuger C; Klein H; Goldenberg I; Brenyo A; McNitt S; Merkely B; Zareba W; Moss AJ
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):645-51. PubMed ID: 24963007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence that conflict regarding size of haemodynamic response to interventricular delay optimization of cardiac resynchronization therapy may arise from differences in how atrioventricular delay is kept constant.
    Sohaib SM; Kyriacou A; Jones S; Manisty CH; Mayet J; Kanagaratnam P; Peters NS; Hughes AD; Whinnett ZI; Francis DP
    Europace; 2015 Dec; 17(12):1823-33. PubMed ID: 25855674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of Myocardial Contractility by SonR Sensor in Patients Undergoing Cardiac Resynchronization Therapy.
    Sacchi S; Perini AP; Attanà P; Grifoni G; Chiostri M; Ricciardi G; Pieragnoli P; Padeletti L
    Pacing Clin Electrophysiol; 2016 Mar; 39(3):268-74. PubMed ID: 26644068
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical outcomes in cardiac resynchronization therapy-defibrillator recipients 80 years of age and older.
    Adelstein EC; Liu J; Jain S; Schwartzman D; Althouse AD; Wang NC; Gorcsan J; Saba S
    Europace; 2016 Mar; 18(3):420-7. PubMed ID: 26487669
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
    Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
    Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Optimized programming during cardiac resynchronization therapy].
    Deneke T; Lemke B; Horlitz M; Drüke A; Mügge A; Grewe PH; Lawo T
    Herzschrittmacherther Elektrophysiol; 2008 Mar; 19(1):11-8. PubMed ID: 18330671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of AV delay and VV delay on left atrial pressure and waveform in ambulant heart failure patients: insights into CRT optimization.
    Chan WY; Blomqvist A; Melton IC; Norén K; Crozier IG; Benser ME; Eigler NL; Gutfinger D; Troughton RW
    Pacing Clin Electrophysiol; 2014 Jul; 37(7):810-9. PubMed ID: 24502608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Performance of Anatomically Designed Quadripolar Left Ventricular Leads: Results from the NAVIGATE X4 Clinical Trial.
    Mittal S; Nair D; Padanilam BJ; Ciuffo A; Gupta N; Gallagher P; Goldner B; Hammill EF; Wold N; Stein K; Burke M
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1199-1205. PubMed ID: 27434039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac resynchronization therapy is associated with a reduction in ICD therapies as it improves ventricular function.
    Galve E; Oristrell G; Acosta G; Ribera-Solé A; Moya-Mitjans À; Ferreira-González I; Pérez-Rodon J; García-Dorado D
    Clin Cardiol; 2018 Jun; 41(6):803-808. PubMed ID: 29604094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Importance of Implantable Cardioverter-Defibrillator Back-Up in Cardiac Resynchronization Therapy Recipients: A Systematic Review and Meta-Analysis.
    Barra S; Providência R; Tang A; Heck P; Virdee M; Agarwal S
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26546574
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
    J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of mechanical dyssynchrony in cardiac resynchronization therapy.
    Risum N
    Dan Med J; 2014 Dec; 61(12):B4981. PubMed ID: 25441737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical outcomes with synchronized left ventricular pacing: analysis of the adaptive CRT trial.
    Birnie D; Lemke B; Aonuma K; Krum H; Lee KL; Gasparini M; Starling RC; Milasinovic G; Gorcsan J; Houmsse M; Abeyratne A; Sambelashvili A; Martin DO
    Heart Rhythm; 2013 Sep; 10(9):1368-74. PubMed ID: 23851059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of Interventricular Electrical Delay on Atrioventricular Optimization for Cardiac Resynchronization Therapy.
    Gold MR; Yu Y; Singh JP; Birgersdotter-Green U; Stein KM; Wold N; Meyer TE; Ellenbogen KA
    Circ Arrhythm Electrophysiol; 2018 Aug; 11(8):e006055. PubMed ID: 30354310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The clinical benefit of cardiac resynchronization therapy optimization using a device-based hemodynamic sensor in a patient with dilated cardiomyopathy: a case report.
    Volpicelli M; Covino G; Capogrosso P
    J Med Case Rep; 2015 Dec; 9():289. PubMed ID: 26683613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sustained clinical benefit of cardiac resynchronization therapy in non-LBBB patients with prolonged PR-interval: MADIT-CRT long-term follow-up.
    Stockburger M; Moss AJ; Klein HU; Zareba W; Goldenberg I; Biton Y; McNitt S; Kutyifa V
    Clin Res Cardiol; 2016 Nov; 105(11):944-952. PubMed ID: 27318807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differentiating Ventricular From Supraventricular Arrhythmias Using the Postpacing Interval After Failed Antitachycardia Pacing.
    Bennett MT; Leader N; Sapp J; Parkash R; Gardner M; Healey JS; Thibault B; Sterns L; Essebag V; Birnie D; Sivakumaran S; Nery P; Andrade JG; Krahn AD; Tang A
    Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005921. PubMed ID: 29618476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
    Tajstra M; Gadula-Gacek E; Kurek A; Adamowicz-Czoch E; Olszowski D; Ostręga M; Ciślak A; Pyka Ł; Hawranek M; Lekston A; Poloński L; Gąsior M
    Cardiol J; 2017; 24(5):515-522. PubMed ID: 27734455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiac resynchronization therapy (CRT) with right ventricular sense triggered left ventricular pacing benefits for the hemodynamics compared with standard CRT for chronic congestive heart failure: A cross-over study.
    Pu LJ; Wang Y; Zhao L; Luo ZL; Hua BT; Han MH; Li SM; Yang J; Li L; Peng YZ; Guo T
    Cardiol J; 2015; 22(1):80-6. PubMed ID: 25179313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.
    Alam MB; Munir MB; Rattan R; Flanigan S; Adelstein E; Jain S; Saba S
    Europace; 2014 Feb; 16(2):246-51. PubMed ID: 24099864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.